/AMNI.ST
AMNI.ST Stock - Amniotics AB (publ)
Healthcare|BiotechnologySTO
$0.01+5.88%
+$0.00 (+5.88%) • Sep 27
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.62
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AMNI.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.00
RISK/REWARD1:0.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.53
52W High$0.05
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-1,930,000 | $-1,793,000 | $-2,153,000 | $-1,586,295 | $-281,479 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-29,073,000 | $-46,693,000 | $-51,615,000 | $-30,994,089 | $-10,427,735 |
| Net Income | $-30,870,000 | $-49,399,000 | $-53,623,000 | $-31,000,349 | $-10,429,145 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.01 | $-0.30 | $-0.33 | $-0.17 | $-0.06 |
Company Overview
Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AMNI.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q1 2024
EPS Surprise History
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 20, 2024 | — | — | — | — |
Q2 2024 | May 21, 2024 | — | — | — | — |
Q1 2024 | Feb 22, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 27, 2023 | — | $-0.12 | — | — |
Q3 2023 | Aug 31, 2023 | — | $-0.12 | — | — |
Q2 2023 | May 5, 2023 | — | $-0.13 | — | — |
Q1 2023 | Jan 19, 2023 | — | $-0.06 | — | — |
Q4 2022 | Nov 10, 2022 | — | $-0.35 | — | — |
Q3 2022 | Aug 16, 2022 | — | $-0.22 | — | — |
Q2 2022 | May 10, 2022 | — | $-0.23 | — | — |
Q1 2022 | Feb 17, 2022 | — | $-0.12 | — | — |
Q4 2021 | Nov 12, 2021 | — | $-0.21 | — | — |
Q3 2021 | Aug 27, 2021 | — | $-0.45 | — | — |
Q3 2021 | Jul 8, 2021 | — | $-0.26 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.87 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.13 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.50 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.12 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AMNI.ST
What is AMNI.ST's current stock price?
Amniotics AB (publ) (AMNI.ST) is currently trading at $0.01 per share. The stock has moved +5.88% today.
What is the analyst price target for AMNI.ST?
No analyst price targets are currently available for this stock.
What sector is Amniotics AB (publ) in?
Amniotics AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is AMNI.ST's market cap?
Amniotics AB (publ) has a market capitalization of $0.01 billion, making it a small-cap company.
Does AMNI.ST pay dividends?
No, Amniotics AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorASAP.ST
Asarina Pharma AB (publ)
$0.03
Mkt Cap: $0.0B
CLINE-B.ST
Cline Scientific AB (publ)
$0.07
Mkt Cap: $0.0B
CYXO.ST
Cyxone AB (publ)
$0.02
Mkt Cap: $0.0B
DIABIO.ST
Diagonal Bio AB (publ)
$0.01
Mkt Cap: $0.0B
IDOGEN.ST
Idogen AB (publ)
$0.12
Mkt Cap: $0.0B
KAN.ST
Kancera AB (publ)
$0.30
Mkt Cap: $0.0B
PHARM.ST
Pharmiva AB (publ)
$0.56
Mkt Cap: $0.0B
REDW.ST
Redwood Pharma AB
$1.19
Mkt Cap: $0.0B
SCOL.ST
Scandion Oncology A/S
$0.00
Mkt Cap: $0.0B
ZICC.ST
Ziccum AB (publ)
$0.25
Mkt Cap: $0.0B
Explore stocks similar to AMNI.ST for comparison